CME webinar: Vaccination Acceptance & Addressing Today’s Challenges

Mar. 2023Education/Webinars
"Please join us for a live, CME-accredited webinar Wednesday, May 17, from noon to 1 p.m. that will provide an overview of how to address vaccine acceptance. This webinar is being offered as part of the Pediatric Collaborative Call series.

During this presentation, experts will discuss:
  • The history of vaccine development, effectiveness, and attitudes.
  • Current trends in vaccination rates.
  • The challenge of vaccine hesitancy.

Presenters:
  • Andrew Nowalk, MD, PHD, Associate Professor of Pediatrics, University of Pittsburgh; Clinical Director of Infectious Diseases, UPMC Children’s Hospital of Pittsburgh; Co-Director, Pediatrics Residency Program, UPMC Children’s Hospital of Pittsburgh
  • Mary Ann Rigas, MD, FAAP, Medical Director of Pediatrics, UPMC Cole; President, Pennsylvania Chapter of the American Academy of Pediatrics
  • Todd Wolynn, MD, MMM, IBCLC, CEO—Kids Plus Pediatrics; Advisory Board President, Shots Heard Round the World
  • Deborah Moss, MD, MPH, FAAP, Professor of Pediatrics, Children’s Hospital of Pittsburgh; Pediatric Medical Director, UPMC Health Plan
  • Robert Rutkowski, MD, FAAP, Medical Director, Practice Transformation and Provider Relations, UPMC Health Plan; Co-Lead Physician, UPMC CCP Children’s Community Pediatrics, Shenango
  • Alin Severance, MD, Medical Director, Behavioral Health Services, UPMC Health Plan; Associate Medical Director, Community Care Behavioral Health Organization

Register now. This webinar will be recorded.

You may earn continuing medical education (CME) credits for attending this webinar. This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Provider is responsible for verifying CME eligibility."

Recent Announcements

Voluntary nationwide recall: Atorvastatin (Alkem – October)

Ascend Laboratories LLC is recalling multiple lots of Atorvastatin Calcium Tablets USP. Atorvastatin is used for the treatment of high cholesterol and to reduce the risk of certain cardiovascular events, such as heart attack and stroke.
Nov. 2025Pharmacy Updates

October 2025 UPMC for You and UPMC Community HealthChoices formulary update

Effective Oct. 1, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to nonparticipation in the Medicaid Drug Rebate Program.
Oct. 2025Pharmacy Updates

Voluntary nationwide recall: Ocaliva (Intercept – September)

Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).
Oct. 2025Pharmacy Updates